Proteasomal Degradation of TRAF2 Mediates Mitochondrial Dysfunction in Doxorubicin-Cardiomyopathy

MLA

Dhingra, Rimpy, et al. “Proteasomal Degradation of TRAF2 Mediates Mitochondrial Dysfunction in Doxorubicin-Cardiomyopathy.” Circulation (Ovid), vol. 146, no. 12, Sept. 2022, pp. 934–54. EBSCOhost, https://doi.org/10.1161/CIRCULATIONAHA.121.058411.

APA

Dhingra, R., Rabinovich-Nikitin, I., Rothman, S., Guberman, M., Gang, H., Margulets, V., Jassal, D. S., Alagarsamy, K. N., Dhingra, S., Valenzuela Ripoll, C., Billia, F., Diwan, A., Javaheri, A., & Kirshenbaum, L. A. (2022). Proteasomal Degradation of TRAF2 Mediates Mitochondrial Dysfunction in Doxorubicin-Cardiomyopathy. Circulation (Ovid), 146(12), 934–954. https://doi.org/10.1161/CIRCULATIONAHA.121.058411

Chicago

Dhingra, Rimpy, Inna Rabinovich-Nikitin, Sonny Rothman, Matthew Guberman, Hongying Gang, Victoria Margulets, Davinder S. Jassal, et al. 2022. “Proteasomal Degradation of TRAF2 Mediates Mitochondrial Dysfunction in Doxorubicin-Cardiomyopathy.” Circulation (Ovid) 146 (12): 934–54. doi:10.1161/CIRCULATIONAHA.121.058411.